Photodynamic Effects of Epirubicin on Triple Negative Breast Cancer Cells

Photodynamic Effects of Epirubicin on Triple Negative Breast Cancer Cells

碩士 === 中山醫學大學 === 醫學研究所 === 102 === Background: Epirubicin is a common chemotherapy medicine for treating Triple-negative breast cancer (TNBC). In addition to its photosensitivity, epirubicin can be accumulated to a harmful dosage that may cause serious heart problems because of its cardiotoxicity....

Full description

Bibliographic Details
Main Authors:	Hung-Ting Lin, 林弘婷
Other Authors:	Fung-Jou Lu
Format:	Others
Language:	zh-TW
Published:	2014
Online Access:	http://ndltd.ncl.edu.tw/handle/41865874043964173278

Similar Items

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
by: Han T, et al.
Published: (2015-07-01)

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
by: Li X, et al.
Published: (2020-09-01)

Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression
by: Fengliang Wang, et al.
Published: (2021-03-01)

Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
by: Hanyi Fang, et al.
Published: (2021-03-01)

Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Triple-Negative Breast Cancer Cells
by: Meden F. Isaac-Lam, et al.
Published: (2019-02-01)

Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells
by: Rachel S. Riley, et al.
Published: (2018-08-01)

Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
by: Yinan Ding, et al.
Published: (2021-05-01)

Effect of cisplatin on triple negative breast cancer cells
by: Ahmedelnour, Hend Salaheldien
Published: (2017)

Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies
by: Yi-Te Chou, et al.
Published: (2021-03-01)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
by: Swanner J, et al.
Published: (2015-06-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

The extracts of Sterculia Nobililis induced G1 phase arrest and apoptosis in triple-negative breast cancer cells
by: Yu-Hung Ye, et al.
Published: (2012)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
by: So-Yeon Park, et al.
Published: (2019-07-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Effect of Two Administration Methods of Endostar Combined with Epirubicin on Breast Cancer in Mice
by: WU Jiao, et al.
Published: (2018-07-01)

The Effect of Small Organic Compounds on Triple Negative Breast Cancer Cells
by: O'Brien, John D.
Published: (2012)

The Effects and Mechanisms of a Novel Epirubicin in Liposomes on Cancer Cells
by: Hsin-Pin Lee, et al.
Published: (2014)

The correlation between PKCα and AXL in human triple-negative breast cancer cells
by: Yi-Hsuan Lin, et al.
Published: (2017)

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
by: Poole, Christopher J., et al.
Published: (2006)

Investigating the anti-tumor efficacy of water-soluble fraction of Ganoderma lucidum on triple-negative breast cancer cells
by: Yu-Ting Chu, et al.
Published: (2017)

TMEPAI genome editing in triple negative breast cancer cells
by: Bantari W.K. Wardhani, et al.
Published: (2017-05-01)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
by: Huebschman ML, et al.
Published: (2015-08-01)

Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells
by: Kayla A. Lewis, et al.
Published: (2018-12-01)

The redox regulation of epirubicin in human colon cancer cells
by: 黃怡萍

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
by: Wen-Hung Kuo, et al.
Published: (2012-01-01)

Estrogen Actions in Triple-Negative Breast Cancer
by: Oliver Treeck, et al.
Published: (2020-10-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-01-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-05-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-07-01)

Clinicopathological Study of Triple Negative Breast Cancers
by: Gunadala Ishitha, et al.
Published: (2016-09-01)

Metabolic reprogramming in triple-negative breast cancer
by: Zhanyu Wang, et al.
Published: (2020-02-01)

Drug Repurposing for Triple-Negative Breast Cancer
by: Marta Ávalos-Moreno, et al.
Published: (2020-10-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-04-01)

Immunohistochemical Differentiation of Triple Negative Breast Cancer
by: Nikola Lesar, et al.
Published: (2016-01-01)

MicroRNAs and Triple Negative Breast Cancer
by: Marilena V. Iorio, et al.
Published: (2013-11-01)

Targeting EGFR in Triple Negative Breast Cancer
by: Naoto T. Ueno, Dongwei Zhang
Published: (2011-01-01)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
by: Domenico Ribatti, et al.
Published: (2016-10-01)

Molecular basis of the triple negative breast cancer
by: Ayse Feyda Nursal
Published: (2015-06-01)